Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

opdivo_1_1

BMS’ blockbuster Opdivo flies high and falls short in non-small cell lung cancer

July 25, 2019 Research and Development Bristol-Myers Squibb, NSCLC, immuntherapy, lung cancer, opdivo, pharma

Bristol-Myers Squibb has pulled back the veil on new data from two analyses of its blockbuster immunotherapy Opdivo (nivolumab) in …
News
30805878966_19824f12fd_z

MRI scans can help predict MS patient’s long term prognosis, 15 year study shows

July 25, 2019 Research and Development CIS, MRI scans, MS, Prognosis, diagnosis, multiple sclerosis, pharma

MRI scans can predict MS patient’s long term prognosis when they are first diagnosed, according to new research. In a …
News
opioid_naloxone_device

Researchers design automatic opioid overdose antidote device

July 25, 2019 Research and Development naloxone, opioid crisis, opioids, pharma, purdue university

Researchers at Purdue University are developing a device that would automatically detect an overdose in opioid users and release a …
News
jonathan_symonds

GSK hire Jonathan Symonds as new Chairman

July 24, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Business chief Jonathan Symonds has joined British multinational GlaxoSmithKline as the company’s new non-executive chairman. The hire ends GSK’s six …
Appointment
mike-thompson-blue-bg

ABPI Chief Executive Mike Thompson to retire by the end of 2019

July 24, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Chief Executive Mike Thompson is to retire from his role at the Association of the British Pharmaceutical Industry (ABPI) by …
Appointment
humira_abbott__4

Humira biosimilar from Samsung Bioepis and MSD wins marketing authorisation in the US

July 24, 2019 Research and Development, Sales and Marketing AbbVie, Humira, MSD, Samsung Bioepis, biosimilars, pharma

It’s another victory for MSD as the US drugmaker announced that its biosimilar version of AbbVie’s Humira – the world’s …
News

Senate puts forward bipartisan bill to lower price of drugs

July 24, 2019 Research and Development PBMs, Senate, USA, access, bipartisan, pharma, pricing

The Senate Finance Committee has introduced a bipartisan bill that aimed at lowering the prices Medicare pays for pharmaceutical drugs. …
News
fda2outsideweb

FDA approves Pfizer’s biosimilar version of Genentech’s Rituxan

July 24, 2019 Research and Development FDA, Pfizer, Rituxan, Ruxience, biosimilars, pharma

Pfizer has seen Ruxience, its biosimilar version of Genentech’s Rituxan (rituximab), approved by the FDA in the treatment of non-Hodgkin …
News

Researchers use machine learning to re-identify ‘anonymous data’

July 24, 2019 Research and Development Big Data, anonymous data, data, patient data, privacy, research

Anonymised data can be traced back to individuals, according to research published in the journal Nature Communications. Anonymised data can …
News
1920px-hiv-budding-color

MSD trials long lasting PrEP implant for preventing HIV

July 23, 2019 Research and Development AIDS, HIV, MSD, PrEP, pharma

MSD is trialling an implant that prevents patients from contracting HIV, The Guardian has said. The US firm has tested …
News
dr_alvin_shih

Disarm Therapeutics hires Dr Alvin Shih as new President and CEO

July 23, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Massachusetts-based biotech Disarm Therapeutics has hired Dr Alvin Shih as their new President and CEO. The Cambridge, Mass.-based firm has …
Appointment
takeda_usa_pharmaceuticals_u

Takeda’s subcutaneous formulation of Entyvio smashes primary endpoint in Crohn’s disease

July 23, 2019 Manufacturing and Production, Research and Development Crohn’s disease, Entyvio, Takeda, crohn's disease, pharma

Takeda has unveiled new Phase 3 data for a subcutaneous formulation of its gut-selective biologic Entyvio (vedolizumab), showing that the …
News
bottle_of_lies_3d_bookshot_w_logo_

Diagnosing the drug supply: Exposing the bad practice of manufacturers in the developing world

July 22, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cipla, Contamination, FDA, India, chin, compliance, manufacturing, pharma, regulation, valsartan

The world needs cheap generic drugs and Indian manufacturers offer a steady supply. However the quality of generics has been …
Feature
mouse

Number of UK animal testing procedures falls to lowest level since 2007

July 19, 2019 Medical Communications, Research and Development Animal testing, UK, drug development, pharma, rresearch

A report from the Home Office of the UK Government has revealed that the prevalence of animal testing in the …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

July 19, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AMAL Therapeutics, Alzheimer's Ebola, Amgen, AstraZeneca, EMA, FDA, Novartis, pharma

On 12 July news broke that Novartis, Amgen and Banner’s Alzheimer’s Institute were discontinuing a trial into investigational compound CNP520 …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026